Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
Trial ID or NCT#
NCT03206216
Status
NOT RECRUITING
Purpose
This clinical trial studies how well Diode laser fiber type Selective Stimulator (DLss) works in predicting pain development in patients with ovarian cancer who are receiving chemotherapy. Stimulating of the pain nerve fibers in the skin with laser light stimulation may help to predict whether a patient will develop painful peripheral neuropathy, correlate with the severity of neuropathy during and after chemotherapy treatment, and may help to explain the mechanisms of chemotherapy-induced neuropathic pain (CIPN).
Official Title
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Investigator(s)
Oliver Dorigo, M.D., Ph.D.
Gynecologic oncologist,
Medical oncologist,
Gynecologic oncologist
Mary Lake Polan Professor
Seema Nagpal, MD
Neuro-oncologist
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor (By courtesy), Neurosurgery
Contact us to find out if this trial is right for you.
Contact
Mark Santos
650-498-5189
View on ClinicalTrials.gov
